Peregrine Pharmaceuticals reported $62K in Ordinary Share Capital for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agenus AGEN:US $ 2.67M 0.1M
Amgen AMGN:US $ 31247M 849M
AstraZeneca AZN:LN 387M 0M
Biocryst Pharmaceuticals BCRX:US $ 1.86M 0.01M
Bristol Myers Squibb BMY:US $ 292M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0M
Chemocentryx CCXI:US $ 0.07M 0M
Eli Lilly And LLY:US $ 594.1M 2.2M
GlaxoSmithKline GSK:LN 1347M 0M
Immunogen IMGN:US $ 2.2M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.61M 0M
Mannkind MNKD:US $ 2.52M 0.01M
Merk MRK:US $ 1788M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Newlink Genetics NLNK:US $ 0.08M 0M
Novartis NOVN:VX SF 901M 0M
Novavax NVAX:US $ 0.79M 0.02M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Repligen RGEN:US $ 0.55M 0M
Xencor XNCR:US $ 0.6M 0M